The stable treated eye

Scanlon, Peter H ORCID: 0000-0001-8513-710X (2017) The stable treated eye. In: Practical Manual of Diabetic Retinopathy Management, 2nd edition. Wiley Blackwell, Oxford, pp. 160-170. ISBN 9781119058953

Full text not available from this repository.

Abstract

A good result following treatment of centre‐involving or diffuse diabetic macular oedema with vascular endothelial growth factor (VEGF) inhibitor injections is resolution of the oedema with improvement in visual acuity. The recommendations that were a modification of the Early Treatment Diabetic Retinopathy study technique were to apply laser to all areas of diffuse leakage or non‐perfusion within the area considered for grid treatment, but not within 500 microns of the foveal centre. New vessels on disc (NVD) and new vessels elsewhere (NVE) usually respond well to laser treatment. Involution of neovascularisation is dependent upon a sufficient area of retinal ablation, which depends on the extent of the retinal ischaemia. However, if there is ischaemia that involves the central fovea, laser treatment in isolation is unlikely to improve the vision. Treatment with VEGF inhibitors for diabetic maculopathy will suppress any neovascularisation.

Item Type:	Book Section
Additional Information:	Chapter 12
Uncontrolled Keywords:	Diabetic retinopathy
Subjects:	R Medicine > RA Public aspects of medicine > RA645.A-Z Individual diseases or groups of diseases, A-Z > RA645.D54 Diabetes R Medicine > RE Ophthalmology
Divisions:	Schools and Research Institutes > School of Education and Science
Research Priority Areas:	Health, Life Sciences, Sport and Wellbeing
Depositing User:	Susan Turner
Date Deposited:	20 Aug 2018 12:29
Last Modified:	31 Aug 2023 09:09
URI:	https://eprints.glos.ac.uk/id/eprint/5896

University Staff: Request a correction | Repository Editors: Update this record